Abstract:Introduction Bipolar Disorder (BD) is a severely debilitating psychiatric disorder with high rates of morbidity and mortality, and patients with BD have a 10-year reduction in their life expectancy. Bipolar disorder (BD) is frequently associated with type 2 diabetes mellitus (T2DM). BD patients with comorbid T2DM have been shown to have three times higher odds of a chronic course and rapid cycling and are more likely to present worse outcomes to treatment with lithium and/or other mood stabilisers when compared to BD patients without IGM (impaired glucose metabolism). Objectives The functioning of the hypothalamic-pituitary-adrenal (HPA) axis has been never investigated in BD with respect to the glucose metabolic status. Therefore, we assessed the cortisol awakening response (CAR) in bipolar patients with or without comorbid T2DM. Methods Twenty euglycemic bipolar patients [12 males and eight females; mean age (±SD): 47.4 ± 14.4 years; mean (±SD) duration of illness: 18.3 ± 12.1 years], 16 BD patients with T2DM [11 males and five females; mean age (±SD): 63.6 ± 12.8 years; mean (±SD) duration of bipolar illness: 17.1 ± 10.8 years; mean (±SD) duration of T2DM: 5.2 ± 5.3 years], 18 healthy subjects [seven males and 11 females; mean age (±SD): 45.0 ± 12.1 years] and 12 non-psychiatric subjects with T2DM [eight males and four females; mean age (±SD): 56.7 ± 11.2 years; mean (±SD) duration of T2DM: 5.2 ± 3.5 years] were recruited. Saliva cortisol was measured at awakening and after 15, 30, and 60 min. Results With respect to both healthy controls and controls with T2DM, euglycemic and diabetic BD patients exhibited a CAR occurring at significantly lower levels. No significant difference emerged in the CAR between the two groups of bipolar patients. Controls with T2DM had an overall post-awakening cortisol production significantly higher than healthy controls. Conclusions Our results show that the CAR of patients with BD is reduced in terms of overall cortisol production but normal in terms of cortisolo reactivity independently from the occurrence of comorbid T2DM. The dampened CAR points to a tuning down of the functioning of the HPA axis in both euglycemic and diabetic BD patients, which may be a factor of vulnerability, since a preserved HPA axis functioning is essential to deal with stressors, which may precipitate affective episodes Disclosure of Interest None Declared

Investigation of the Plasma Cortisol and the Function of Hypothalamic-Pituitary-adrenal Axis in Type 2 Diabetic Patients

The Changes in the Cortisol Secretion and Regulation in the Patients with Type 2 Diabetes

Hypothalamic-pituitary-adrenal Axis in Postmenopausal Women with Type 2 Diabetes Mellitus and Visceral Obesity

In Search of the HPA Axis Activity in Unipolar Depression Patients with Childhood Trauma: Combined Cortisol Awakening Response and Dexamethasone Suppression Test

Dysregulation of Hypothalamo-Pituitary-Adrenocortical Axis in Overweight Female Diabetic Subjects is Associated with Downregulation of Corticosteroid Receptors and 11Β-Hsd1 in the Brain

Relationship Between Secretion of Cortisol and Higher Blood Glucose in Patients with Diabetes Mellitus

Relation Between Hypothalamic-Pituitary-adrenal Axis Activity and Insulin Resistance in Woman with Polycystic Ovary Syndrome

11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent

Stronger Association Between Morning Serum Cortisol Level and Diurnal Time in Range in Type 2 Diabetes?

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

Mineralocorticoids, Glucose Homeostasis and Type 2 Diabetes Mellitus: the Henan Rural Cohort Study

Neuroendocrine–immune Disorder in Type 2 Diabetic Patients with Retinopathy

Cortisol awakening response in bipolar patients with comorbid type 2 diabetes mellitus

Expression of Pituitary Glucocorticoid Receptor and 11Β-Hydroxysteroid Dehydrogenase 1 in Obese Diabetic Rats

Assessment of blood cortisol levels in patients with diabetic foot syndrome

Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus

Who and how to screen for endogenous hypercortisolism in type 2 diabetes mellitus or obesity

Gender-Specific Independent and Combined Effects of the Cortisol-to-Cortisone Ratio and 11-Deoxycortisol on Prediabetes and Type 2 Diabetes Mellitus: from the Henan Rural Cohort Study

11Β-Hydroxysteroid Dehydrogenase Type 1 Shrna Ameliorates Glucocorticoid-Induced Insulin Resistance and Lipolysis in Mouse Abdominal Adipose Tissue.

Analysis of Sex Hormones, Insulin Dosage, and Risk Factors Associated With Male Diabetic Patients

Correlation of lower 2 h C-peptide and elevated evening cortisol with high levels of depression in type 2 diabetes mellitus